Barclays’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.6K | Sell |
1,926
-14,843
| -89% | -$160K | ﹤0.01% | 4581 |
|
|
2025
Q4 | $179K | Buy |
16,769
+1,608
| +11% | +$19.2K | ﹤0.01% | 4384 |
|
|
2025
Q3 | $207K | Sell |
15,161
-2,627
| -15% | -$36.7K | ﹤0.01% | 4271 |
|
|
2025
Q2 | $250K | Buy |
17,788
+6,991
| +65% | +$91.9K | ﹤0.01% | 4141 |
|
|
2025
Q1 | $146K | Sell |
10,797
-5,397
| -33% | -$81.1K | ﹤0.01% | 4230 |
|
|
2024
Q4 | $285K | Buy |
16,194
+2,127
| +15% | +$39.5K | ﹤0.01% | 4138 |
|
|
2024
Q3 | $269K | Sell |
14,067
-1,275
| -8% | -$24.6K | ﹤0.01% | 4146 |
|
|
2024
Q2 | $335K | Sell |
15,342
-16,022
| -51% | -$427K | ﹤0.01% | 3279 |
|
|
2024
Q1 | $1.2M | Buy |
31,364
+10,912
| +53% | +$529K | ﹤0.01% | 2971 |
|
|
2023
Q4 | $1.37M | Buy |
20,452
+14,050
| +219% | +$979K | ﹤0.01% | 3206 |
|
|
2023
Q3 | $479K | Sell |
6,402
-1,365
| -18% | -$121K | ﹤0.01% | 2832 |
|
|
2023
Q2 | $716K | Sell |
7,767
-2,849
| -27% | -$254K | ﹤0.01% | 2531 |
|
|
2023
Q1 | $1.1M | Buy |
10,616
+774
| +8% | +$85.8K | ﹤0.01% | 2662 |
|
|
2022
Q4 | $1.14M | Buy |
9,842
+3,161
| +47% | +$368K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $724K | Buy |
6,681
+850
| +15% | +$122K | ﹤0.01% | 2457 |
|
|
2022
Q2 | $1.05M | Sell |
5,831
-5,959
| -51% | -$1.07M | ﹤0.01% | 2306 |
|
|
2022
Q1 | $2.01M | Sell |
11,790
-4,855
| -29% | -$915K | ﹤0.01% | 1858 |
|
|
2021
Q4 | $3.49M | Buy |
16,645
+847
| +5% | +$175K | ﹤0.01% | 1974 |
|
|
2021
Q3 | $3.04M | Buy |
15,798
+5,734
| +57% | +$1.41M | ﹤0.01% | 2009 |
|
|
2021
Q2 | $2.85M | Sell |
10,064
-7,374
| -42% | -$2M | ﹤0.01% | 1950 |
|
|
2021
Q1 | $3.69M | Buy |
17,438
+3,249
| +23% | +$777K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $2.79M | Sell |
14,189
-287
| -2% | -$50.7K | ﹤0.01% | 1980 |
|
|
2020
Q3 | $2.38M | Buy |
14,476
+3,524
| +32% | +$580K | ﹤0.01% | 1952 |
|
|
2020
Q2 | $1.52M | Buy |
10,952
+55
| +0.5% | +$5.05K | ﹤0.01% | 2380 |
|
|
2020
Q1 | $681K | Sell |
10,897
-5,999
| -36% | -$546K | ﹤0.01% | 3329 |
|
|
2019
Q4 | $1.85M | Buy |
16,896
+147
| +0.9% | +$14.2K | ﹤0.01% | 3092 |
|
|
2019
Q3 | $1.74M | Sell |
16,749
-8,505
| -34% | -$914K | ﹤0.01% | 3044 |
|
|
2019
Q2 | $3.24M | Buy |
25,254
+16,494
| +188% | +$2.29M | ﹤0.01% | 2339 |
|
|
2019
Q1 | $1.12M | Sell |
8,760
-815
| -9% | -$103K | ﹤0.01% | 3291 |
|
|
2018
Q4 | $1.2M | Sell |
9,575
-6,778
| -41% | -$1.16M | ﹤0.01% | 2932 |
|
|
2018
Q3 | $3.62M | Sell |
16,353
-6,636
| -29% | -$1.35M | ﹤0.01% | 2160 |
|
|
2018
Q2 | $3.68M | Buy |
22,989
+16,652
| +263% | +$2.13M | ﹤0.01% | 1990 |
|
|
2018
Q1 | $592K | Sell |
6,337
-1,054
| -14% | -$78.8K | ﹤0.01% | 3797 |
|
|
2017
Q4 | $515K | Buy |
7,391
+3,281
| +80% | +$218K | ﹤0.01% | 3799 |
|
|
2017
Q3 | $244K | Buy |
4,110
+2,779
| +209% | +$138K | ﹤0.01% | 4263 |
|
|
2017
Q2 | $55K | Sell |
1,331
-3,105
| -70% | -$135K | ﹤0.01% | 5296 |
|
|
2017
Q1 | $197K | Buy |
4,436
+3,452
| +351% | +$149K | ﹤0.01% | 4338 |
|
|
2016
Q4 | $41K | Sell |
984
-6,777
| -87% | -$273K | ﹤0.01% | 5288 |
|
|
2016
Q3 | $293K | Buy |
7,761
+2,346
| +43% | +$84.1K | ﹤0.01% | 3646 |
|
|
2016
Q2 | $180K | Sell |
5,415
-81
| -1% | -$2.61K | ﹤0.01% | 3992 |
|
|
2016
Q1 | $165K | Buy |
5,496
+96
| +2% | +$2.81K | ﹤0.01% | 3979 |
|
|
2015
Q4 | $162K | Buy |
5,400
+5,085
| +1,614% | +$151K | ﹤0.01% | 4078 |
|
|
2015
Q3 | $8K | Sell |
315
-296
| -48% | -$8.62K | ﹤0.01% | 5869 |
|
|
2015
Q2 | $20K | Sell |
611
-1,761
| -74% | -$55.8K | ﹤0.01% | 5678 |
|
|
2015
Q1 | $70K | Sell |
2,372
-8,315
| -78% | -$264K | ﹤0.01% | 5066 |
|
|
2014
Q4 | $353K | Buy |
10,687
+991
| +10% | +$30.9K | ﹤0.01% | 4181 |
|
|
2014
Q3 | $309K | Buy |
9,696
+9,369
| +2,865% | +$288K | ﹤0.01% | 4378 |
|
|
2014
Q2 | $11K | Sell |
327
-3,110
| -90% | -$96.9K | ﹤0.01% | 6785 |
|
|
2014
Q1 | $100K | Sell |
3,437
-15,452
| -82% | -$414K | ﹤0.01% | 5454 |
|
|
2013
Q4 | $492K | Sell |
18,889
-8,929
| -32% | -$229K | ﹤0.01% | 4110 |
|
|
2013
Q3 | $724K | Sell |
27,818
-6,932
| -20% | -$185K | ﹤0.01% | 3698 |
|
|
2013
Q2 | $895K | Buy |
+34,750
| New | +$913K | ﹤0.01% | 3529 |
|
Other funds holding MED
SCP
VCM
Barclays's MED Position: Q1 2026 in Review
Barclays reduced its Medifast (MED) stake by 89% in Q1 2026, selling an estimated $160K and leaving 1,926 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4581.
Barclays first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.69M in Q1 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Barclays held 1,926 shares of Medifast worth $19.6K as of Q1 2026.
- Barclays sold 14,843 Medifast shares in Q1 2026, an estimated $160K.
- Medifast made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4581 holding.
- Barclays first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
- Barclays's Medifast position peaked at $3.69M in Q1 2021.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.